Relapsing insulin-induced lipoatrophy, cured by prolonged low-dose oral prednisone: A case report

Diabetology and Metabolic Syndrome

Volumn 3, Issue 1, 2011, Pages

  Chantelau, Ernst A ^a   Praetor, Ruth ^b   Praetor, Jörg ^b   Poll, Ludger W ^c  

^a Practice of Endocrinology and Diabetology   (Germany)

^b Berufsgenossenschaftliche Unfallklinik Duisburg GmbH ^*  (Germany)

^c BG Unfallklinik Duisburg GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN LISPRO; PREDNISONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; LIPOATROPHY; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; PRIORITY JOURNAL; RELAPSE; SUBCUTANEOUS FAT;

EID: 82655162454     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-3-33     Document Type: Article

References (20)

1. Insulin-induced lipoatrophy: evidence for an immune pathogenesis. Reeves WG, Allen BR, Tattersall RB, Br Med J 1980 280 1500 1503 10.1136/bmj.280.6230. 1500 6992934 (Pubitemid 10122471)
2. Fat atrophy in human insulin therapy. (Letter). Rosman MS, Diabetes Care 1986 9 436 3743326 (Pubitemid 16040617)
3. A Case of lipoatrophy with human insulin-therapy. Chantelau E, Reuter M, Schotes S, Starke AAR, Exp Clin Endocrinol Diabetes 1993 101 194 196 10.1055/s-0029-1211231 (Pubitemid 23270632)
4. Human insulin-induced lipoatrophy. Logwin S, Conget I, Jansa M, Vidal M, Nicolau C, Gomis R, Diabetes Care 1996 19 255 256 10.2337/diacare.19.3.255 8742573
5. 'Lipoblastoma-like' lipoatrophy induced by human insulin-morphological evidence for local dedifferentiation of adipocytes? (Letter). Jermendy G, Nadas J, Sapi Z, Diabetologia 2000 43 955 956 10.1007/s001250051476 10952472 (Pubitemid 30463179)
6. Lipoatrophy associated with lispro insulin in insulin pump therapy. (Letter). Griffin ME, Feder A, Tamborlane WV, Diabetes Care 2001 24 174 10.2337/diacare.24.1.174 11194227 (Pubitemid 32104241)
7. A case of lipoatrophy with insulin glargine. (Letter). Ampudia-Blasco FJ, Girbes J, Carmena R, Diabetes Care 2005 28 2983 16331868
8. Lipoatrophy induced by subcutaneous administration of octreotide in the treatment of acromegaly. Atmaca A, Erbas T, Exp Clin Endocrinol Diabetes 2005 113 340 343 10.1055/s-2005-837664 15977102 (Pubitemid 40896009)
9. Human insulin-induced lipoatrophy. Successful treatment with glucocorticoid. Ramos AJS, Farias MA, Diabetes Care 2006 29 926 927 10.2337/diacare.29.04.06.dc06-0004 16567840 (Pubitemid 44115319)
10. Human insulin analog-induced lipoatrophy. Lopez X, Castells MC, Ricker A, Velazquez EF, Mun E, Goldfine AB, Diabetes Care 2008 31 442 444 18162498
11. A case of lipoatrophy with lispro insulin without insulin pump therapy. (Letter). Arranz A, Andia V, Lopez-Guzman A, Diabetes Care 2004 27 625 626 10.2337/diacare.27.2.625 14747261 (Pubitemid 38174103)
12. Benefits of intra-peritoneal insulin administration in a child with severe insulin-induced lipoatrophy. (Abstract). Noud MN, Renard E, McBride C, Cotterill AM, Harris M, Pediatric Diabetes 2009 10 Suppl 11 100 19754622
13. Injection-site lipoatrophy. Sackey AH, New Engl J Med 2009 361 41 10.1056/NEJMicm0808275 19890122
14. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature. Holstein A, Stege H, Kovacs P, Exp Opin Drug Saf 2009 9 225 231
15. MRI of diabetic cheiroarthropathy. Khanna G, Ferguson P, Am J Roentgen 2007 188 94 W95 10.2214/AJR.06.0672
16. Lipoatrophy with insulin analogues in type 1 diabetes. Babiker A, Datta V, Arch Dis Child 2011 96 101 102 10.1136/adc.2010.183731 20570843
17. Amelioration of insulin lipoatrophy by dexamethasone injection. Whitley TH, Lawrence PA, Smith CL, JAMA 1976 235 839 840 10.1001/jama.1976. 03260340045021 946314
18. Use of dexamethasone in treatment of insulin lipoatrophy. Kumar D, Miller LV, Mehtalia SD, Diabetes 1977 26 296 299 10.2337/diabetes.26.4.296 849810 (Pubitemid 8086530)
19. Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs. Markussen J, Havelund S, Kurtzhals P, Andersen AS, Halstrom J, Hasselager E, Larsen UD, Ribel U, Schäffer L, Vad K, Jonassen I, Diabetologia 1996 39 281 288 10.1007/BF00418343 8721773 (Pubitemid 26064823)
20. Histopathological study of subcutaneous drug infusion sites in patients dying of cancer. (Letter). Oliver DJ, Sykes NP, Carter RL, Lancet 1988 331 478 (Pubitemid 18067705)